BRPI0516134A - neurotoxinas de clostridium para uso na cicatrização de tecidos - Google Patents
neurotoxinas de clostridium para uso na cicatrização de tecidosInfo
- Publication number
- BRPI0516134A BRPI0516134A BRPI0516134-7A BRPI0516134A BRPI0516134A BR PI0516134 A BRPI0516134 A BR PI0516134A BR PI0516134 A BRPI0516134 A BR PI0516134A BR PI0516134 A BRPI0516134 A BR PI0516134A
- Authority
- BR
- Brazil
- Prior art keywords
- neurotoxins
- clostridium
- tissue
- damaged
- healing
- Prior art date
Links
- 239000002581 neurotoxin Substances 0.000 title abstract 6
- 231100000618 neurotoxin Toxicity 0.000 title abstract 6
- 241000193403 Clostridium Species 0.000 title abstract 4
- 230000035876 healing Effects 0.000 title abstract 3
- 229940079593 drug Drugs 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 238000011156 evaluation Methods 0.000 abstract 1
- 239000004744 fabric Substances 0.000 abstract 1
- 208000018931 inflamed eyes Diseases 0.000 abstract 1
- 238000002483 medication Methods 0.000 abstract 1
- 230000037390 scarring Effects 0.000 abstract 1
- 239000003053 toxin Substances 0.000 abstract 1
- 231100000765 toxin Toxicity 0.000 abstract 1
- 230000029663 wound healing Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/08—Clostridium, e.g. Clostridium tetani
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
- A61K38/4886—Metalloendopeptidases (3.4.24), e.g. collagenase
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Microbiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Dermatology (AREA)
- Organic Chemistry (AREA)
- Mycology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Materials For Medical Uses (AREA)
Abstract
NEUROTOXINAS DE CLOSTRIDIUM PARA USO NA CICATRIZAçãO DE TECIDOS. Neurotoxinas de Clostridium de ocorrência natural e/ou modificadas, que incluem aquelas neurotoxinas livres de proteínas de formação de complexo que formam complexos com neurotoxinas de Clostridium, são usadas para melhorar a cicatrização de superfície danificada ou tecido superficial de um paciente por administração local ou na proximidade do tecido danificado. Tais neurotoxinas podem ser vantajosamente empregadas na cicatrização de ferimentos e para evitar a formação de cicatrizes, e têm aplicabilidade na área de oftalmologia, por exemplo, no tratamento de tecido corneano danificado, por exemplo, por fechamento de olhos inflamados. Uma modalidade adicional inclui o uso diagnóstico para a avaliação de administração eficaz de toxina e medicamentos para uso nela.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US61339204P | 2004-09-27 | 2004-09-27 | |
| PCT/GB2005/003728 WO2006035225A1 (en) | 2004-09-27 | 2005-09-27 | Clostridial neurotoxins for use in tissue healing |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BRPI0516134A true BRPI0516134A (pt) | 2008-08-26 |
Family
ID=35355850
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI0516134-7A BRPI0516134A (pt) | 2004-09-27 | 2005-09-27 | neurotoxinas de clostridium para uso na cicatrização de tecidos |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US20060067950A1 (pt) |
| EP (1) | EP1799254A1 (pt) |
| KR (1) | KR20070057862A (pt) |
| CN (1) | CN101027083A (pt) |
| AU (1) | AU2005288758A1 (pt) |
| BR (1) | BRPI0516134A (pt) |
| CA (1) | CA2580122A1 (pt) |
| EA (1) | EA200700739A1 (pt) |
| IL (1) | IL182153A0 (pt) |
| MX (1) | MX2007003407A (pt) |
| NO (1) | NO20072155L (pt) |
| WO (1) | WO2006035225A1 (pt) |
| ZA (1) | ZA200702484B (pt) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7220422B2 (en) * | 2003-05-20 | 2007-05-22 | Allergan, Inc. | Methods and compositions for treating eye disorders |
| US20050220821A1 (en) * | 2004-03-31 | 2005-10-06 | Allergan, Inc. | Pressure sore treatment |
| US10792344B2 (en) | 2006-06-29 | 2020-10-06 | Merz Pharma Gmbh & Co. Kgaa | High frequency application of botulinum toxin therapy |
| AR061669A1 (es) | 2006-06-29 | 2008-09-10 | Merz Pharma Gmbh & Co Kgaa | Aplicacion de alta frecuencia de terapia con toxina botulinica |
| EP2236520A1 (en) * | 2009-03-31 | 2010-10-06 | Leukocare Ag | Stabilizing composition for immobilized biomolecules |
| US10076558B2 (en) | 2014-02-18 | 2018-09-18 | Rnw Skn, Llc | Prophylactic normalization of cutaneous wound repair |
| CA3057302A1 (en) * | 2017-03-22 | 2018-09-27 | Bonti, Inc. | Botulinum neurotoxin serotype e for use in cosmetic treatment |
| CA3057304A1 (en) * | 2017-03-22 | 2018-09-27 | Bonti, Inc. | Botulinum neurotoxins for treating traumatic injuries |
| CN107469065B (zh) * | 2017-07-19 | 2021-05-18 | 广州医科大学 | 类蛇毒三胜肽在制备用于治疗皮肤溃疡的药物中的应用 |
| US20190183987A1 (en) * | 2017-12-18 | 2019-06-20 | Bonti, Inc. | Neurotoxins for use in minimizing scarring |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE216589T1 (de) * | 1996-11-27 | 2002-05-15 | William J Binder | Neurotoxine zur behandlung von hauterkrankungen bei säugetieren |
| CA2347828A1 (en) * | 1998-10-27 | 2000-05-04 | Mayo Foundation For Medical Education And Research | Methods for enhancing wound healing |
| DE19925739A1 (de) * | 1999-06-07 | 2000-12-21 | Biotecon Ges Fuer Biotechnologische Entwicklung & Consulting Mbh | Therapeutikum mit einem Botulinum-Neurotoxin |
| US8048423B2 (en) * | 2003-12-09 | 2011-11-01 | Allergan, Inc. | Botulinum toxin therapy for skin disorders |
-
2005
- 2005-09-27 MX MX2007003407A patent/MX2007003407A/es not_active Application Discontinuation
- 2005-09-27 AU AU2005288758A patent/AU2005288758A1/en not_active Abandoned
- 2005-09-27 US US11/235,775 patent/US20060067950A1/en not_active Abandoned
- 2005-09-27 WO PCT/GB2005/003728 patent/WO2006035225A1/en not_active Ceased
- 2005-09-27 CA CA002580122A patent/CA2580122A1/en not_active Abandoned
- 2005-09-27 BR BRPI0516134-7A patent/BRPI0516134A/pt not_active IP Right Cessation
- 2005-09-27 EA EA200700739A patent/EA200700739A1/ru unknown
- 2005-09-27 CN CNA2005800326132A patent/CN101027083A/zh active Pending
- 2005-09-27 EP EP05787027A patent/EP1799254A1/en not_active Withdrawn
- 2005-09-27 KR KR1020077006802A patent/KR20070057862A/ko not_active Withdrawn
-
2007
- 2007-03-22 IL IL182153A patent/IL182153A0/en unknown
- 2007-03-26 ZA ZA200702484A patent/ZA200702484B/xx unknown
- 2007-04-26 NO NO20072155A patent/NO20072155L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| CA2580122A1 (en) | 2006-04-06 |
| WO2006035225A1 (en) | 2006-04-06 |
| KR20070057862A (ko) | 2007-06-07 |
| AU2005288758A1 (en) | 2006-04-06 |
| US20060067950A1 (en) | 2006-03-30 |
| ZA200702484B (en) | 2008-11-26 |
| IL182153A0 (en) | 2007-07-24 |
| CN101027083A (zh) | 2007-08-29 |
| EP1799254A1 (en) | 2007-06-27 |
| EA200700739A1 (ru) | 2007-10-26 |
| MX2007003407A (es) | 2007-05-23 |
| NO20072155L (no) | 2007-04-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ECSP077328A (es) | Neurotoxinas clostridiales para uso en la cicatrización de tejidos | |
| Paschos et al. | Primary closure versus non-closure of dog bite wounds. A randomised controlled trial | |
| Heinlin et al. | Randomized placebo‐controlled human pilot study of cold atmospheric argon plasma on skin graft donor sites | |
| BRPI0502346A (pt) | processo de tratamento cosmético para prevenir e/ou tratar as peles sensìveis e/ou secas, utilização de uma quantidade eficaz de pelo menos um microorganismo notadamente probiótico e/ou uma de suas frações e/ou um de seus metabólitos e composição cosméticas e/ou dermatológica | |
| BRPI0513200A (pt) | uso de um anticorpo anti-igf-1r na preparação de um medicamento para tratamento combinado para malignidades não-hematológicas | |
| CR9351A (es) | Composiciones y metodos para aplicaicon topica y suministro transdermico de toxina botulinica | |
| BR0210056A (pt) | composições e métodos para tratamento de hiperplasia | |
| ES2249490T3 (es) | Articulos quirurgicos. | |
| CY1107615T1 (el) | Θεραπευτικοι συνδυασμοι αντιυπερτασικων και αντιαγγειογενετικων παραγοντων | |
| ATE554800T1 (de) | Medizinische vorrichtungen mit porösen regionen zur kontrollierten aussetzung oder verabreichung therapeutischer wirkstoffe | |
| BR0315319A (pt) | Terapias e procedimentos dentais com toxina botulìnica | |
| Wollina et al. | Dermal fillers: facts and controversies | |
| NO20072155L (no) | Clostridium-nevrotoksiner for anvendelse i vevheling | |
| Balcin et al. | A comparative study of two methods of surgical treatment for painful neuroma | |
| BRPI0415713A (pt) | mio-inositol hexafosfato para uso tópico | |
| Wang et al. | Intra‐articular injection of hyaluronic acid for the reduction in joint adhesion formation in a rabbit model of knee injury | |
| WO2019118779A3 (en) | Peptides and other agents for treating pain and increasing pain sensitivity | |
| Zhou et al. | Antibiotic prophylaxia in patients with severe acute pancreatitis | |
| Koca et al. | The VY flap technique in complicated and recurrent pilonidal sinus disease | |
| BR0214196A (pt) | Método e composição para reduzir a atividade de inibir o crescimento de uma célula cancerosa, para tratar de paciente com câncer | |
| Korableva et al. | Prospects for use of botulinum toxin type a for prevention of hypertrophic and keloid scars after surgeries | |
| Grunebaum et al. | Lip and perioral trauma | |
| Matthews-Brzozowska et al. | Mesotherapy–a method of facial skin rejuvenation from an interdisciplinary perspective on improving facial aesthetics | |
| BRPI0412506A (pt) | células autólogas que induzem à autotoleráncia de origem monocìtica e seu uso em preparações farmacêuticos | |
| BR0111900A (pt) | Uso de um antagonista do receptor do tipo 1 da angiotensina ii, formulação farmacêutica, e, métodos para o tratamento de uma condição de cefaléia vascular e para o tratamento de enxaqueca |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE AS 3A, 4A, 5A E 6A ANUIDADES. |
|
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2160 DE 29/05/2012. |